Xcellbio develops instrumentation, software, and automated manufacturing platforms for cell and gene therapy research and production
Xcellbio develops instrumentation, software, and automated manufacturing platforms for cell and gene therapy research and production. Its AVATAR platform controls physiologically relevant tumor microenvironment conditions, including oxygen and pressure, to support cell therapy process development, potency assessment, and scalable cGMP manufacturing.
The top three firms on F4's Biotech & Life Sciences investor list.